摘要
从朊病毒蛋白(PrP)的发现到今天已经过去三十多年了,它是成为传染性海绵状脑病的致病原因。自从它获得和失去功能机制合并可能导致传染性海绵状脑病以来,了解朊病毒蛋白生理角色可能在疾病机制方面提供了重要线索。历史上,朊病毒研究的主要策略涉及人类组织、细胞环境和哺乳动物模型的运用。然而,体内研究和有争议的言论在这些系统中存在着实验性困难,这刺激了可替代性动物模型的研究。PrPC在哺乳动物内高度保留的,PrPC相关同源在斑马鱼中表达,脊椎模式生物适用于研究与人类疾病相关机制。脊椎模型,正如它没有表达PrPC,使他们更适应哺乳动物朊病毒蛋白神经毒性机制的调查。在这里,我们回顾在朊病毒蛋白在普通和病理环境下近期研究进展,它基于非哺乳动物研究,强调了斑马鱼,苍蝇和蠕虫对我们理解当代PrP生物所做出的贡献。
关键词: 朊病毒相关疾病、PrPC、生理、神经毒性、哺乳动物、斑马鱼、Drosophila melanogaster、秀丽隐杆线虫。
Current Molecular Medicine
Title:Prion Function and Pathophysiology in Non-Mammalian Models
Volume: 17 Issue: 1
关键词: 朊病毒相关疾病、PrPC、生理、神经毒性、哺乳动物、斑马鱼、Drosophila melanogaster、秀丽隐杆线虫。
摘要: More than thirty years have passed since the discovery of the prion protein (PrP) and its causative role in transmissible spongiform encephalopathy. Since a combination of both gain- and loss-of-function mechanisms may underlay prion pathogenesis, understanding the physiological role of PrP may give important clues about disease mechanisms. Historically, the primary strategy for prion research has involved the use of human tissue, cell cultures and mammalian animal models. Nevertheless, experimental difficulties of in vivo studies and controversial observations obtained in these systems have stimulated the search for alternative animal models. PrPC is highly conserved in mammals, and PrPC-related orthologs are expressed in zebrafish, a vertebrate model organism suitable to study the mechanisms associated with human diseases. Invertebrate models, as they do not express PrPC have served to investigate the neurotoxic mechanisms of mammalian PrP. Here we overview most recent advances in the study of PrP function in normal and pathogenic conditions based on non-mammalian studies, highlighting the contribution of zebrafish, fly and worms to our current understanding of PrP biology.
Export Options
About this article
Cite this article as:
Prion Function and Pathophysiology in Non-Mammalian Models, Current Molecular Medicine 2017; 17 (1) . https://dx.doi.org/10.2174/1566524017666170220100715
DOI https://dx.doi.org/10.2174/1566524017666170220100715 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cooling the Injured Brain: How Does Moderate Hypothermia Influence the Pathophysiology of Traumatic Brain Injury
Current Pharmaceutical Design Pharmacological Treatment of Cognitive Symptoms in Major Depressive Disorder
CNS & Neurological Disorders - Drug Targets Early β-Amyloid-induced Synaptic Dysfunction Is Counteracted by Estrogen in Organotypic Hippocampal Cultures
Current Alzheimer Research Coronary Artery Bypass Graft in HIV-Infected Patients: A Multicenter Case Control Study
Current HIV Research Non-Celiac Gluten Sensitivity Triggers Gut Dysbiosis, Neuroinflammation, Gut-Brain Axis Dysfunction, and Vulnerability for Dementia
CNS & Neurological Disorders - Drug Targets Mechanism of CNS Drugs and their Combinations for Alzheimers Disease
Central Nervous System Agents in Medicinal Chemistry A Review on Hematopoietic Stem Cell Treatment for Epilepsy
CNS & Neurological Disorders - Drug Targets An Overview of EEG Seizure Detection Units and Identifying their Complexity- A Review
Current Signal Transduction Therapy Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs
Current Medicinal Chemistry Codon Usage Biases in Alzheimers Disease and Other Neurodegenerative Diseases
Protein & Peptide Letters Auditory and Visual Mismatch Negativity in Psychiatric Disorders: A Review
Current Psychiatry Reviews Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
CNS & Neurological Disorders - Drug Targets Enhanced Anti-Amyloid Effect of Combined Leptin and Pioglitazone in APP/PS1 Transgenic Mice
Current Alzheimer Research New Insights into the Chemistry and Antioxidant Activity of Coumarins
Current Topics in Medicinal Chemistry Patent Selections:
Recent Patents on Regenerative Medicine Multipotent, Permeable Drug ASS234 Inhibits Aβ Aggregation, Possesses Antioxidant Properties and Protects from Aβ-induced Apoptosis In Vitro
Current Alzheimer Research Epidemiology, Prognosis and Prevention of Non-Traumatic Intracerebral Hemorrhage
Current Pharmaceutical Design Ramelteon in the Treatment of Delirium: New Perspectives from Reported Findings and a Case Observation
Current Drug Therapy Correlations Between Cerebellar and Brain Volumes, Cognitive Impairments, ApoE Levels, and APOE Genotypes in Patients with AD and MCI
Current Alzheimer Research Brain: The Potential Diagnostic and Therapeutic Target for Glaucoma
CNS & Neurological Disorders - Drug Targets